Methionine enkephalin, which has demonstrated efficacy against CRC, in GC also promotes the transition of TAMs from type M2 to type M1 and induces cells apoptosis though blocking the OGFr/PI3K/AKT/mTOR signaling pathway [112]. This evidence concerns the gene MTOR and gastric cancer.